Systematic Review
. 2010 Jul; 134(7):e48-72.
doi: 10.1043/1543-2165-134.7.e48.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)

M Elizabeth H Hammond 1 Daniel F Hayes  Mitch Dowsett  D Craig Allred  Karen L Hagerty  Sunil Badve  Patrick L Fitzgibbons  Glenn Francis  Neil S Goldstein  Malcolm Hayes  David G Hicks  Susan Lester  Richard Love  Pamela B Mangu  Lisa McShane  Keith Miller  C Kent Osborne  Soonmyung Paik  Jane Perlmutter  Anthony Rhodes  Hironobu Sasano  Jared N Schwartz  Fred C G Sweep  Sheila Taube  Emina Emilia Torlakovic  Paul Valenstein  Giuseppe Viale  Daniel Visscher  Thomas Wheeler  R Bruce Williams  James L Wittliff  Antonio C Wolff  American Society of Clinical Oncology  College of American Pathologists  
Affiliations
  • PMID: 20586616
  •     348 citations

Abstract

Purpose: To develop a guideline to improve the accuracy of immunohistochemical (IHC) estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and the utility of these receptors as predictive markers.

Methods: The American Society of Clinical Oncology and the College of American Pathologists convened an international Expert Panel that conducted a systematic review and evaluation of the literature in partnership with Cancer Care Ontario and developed recommendations for optimal IHC ER/PgR testing performance.

Results: Up to 20% of current IHC determinations of ER and PgR testing worldwide may be inaccurate (false negative or false positive). Most of the issues with testing have occurred because of variation in pre-analytic variables, thresholds for positivity, and interpretation criteria.

Recommendations: The Panel recommends that ER and PgR status be determined on all invasive breast cancers and breast cancer recurrences. A testing algorithm that relies on accurate, reproducible assay performance is proposed. Elements to reliably reduce assay variation are specified. It is recommended that ER and PgR assays be considered positive if there are at least 1% positive tumor nuclei in the sample on testing in the presence of expected reactivity of internal (normal epithelial elements) and external controls. The absence of benefit from endocrine therapy for women with ER-negative invasive breast cancers has been confirmed in large overviews of randomized clinical trials.

Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.
José M A Moreira, Teresa Cabezón, +7 authors, Julio E Celis.
Mol Oncol, 2010 Nov 03; 4(6). PMID: 21036680    Free PMC article.
American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, +2 authors, Sarah Temin.
J Oncol Pract, 2010 Nov 03; 6(4). PMID: 21037871    Free PMC article.
Highly Cited.
The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?
Mustafa Khasraw, Edi Brogi, Andrew D Seidman.
Curr Oncol Rep, 2010 Nov 06; 13(1). PMID: 21053108
Review.
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.
Chellappagounder Thangavel, Jeffry L Dean, +5 authors, Erik S Knudsen.
Endocr Relat Cancer, 2011 Mar 04; 18(3). PMID: 21367843    Free PMC article.
Highly Cited.
Female breast cancer status according to ER, PR and HER2 expression: a population based analysis.
Adele Caldarella, Emanuele Crocetti, +4 authors, Marco Zappa.
Pathol Oncol Res, 2011 Apr 12; 17(3). PMID: 21479875
Biospecimen reporting for improved study quality (BRISQ).
Helen M Moore, Andrea B Kelly, +16 authors, Jim Vaught.
J Proteome Res, 2011 May 18; 10(8). PMID: 21574648    Free PMC article.
Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women.
Lisa M Hines, Betsy Risendal, +3 authors, Meenakshi Singh.
J Womens Health (Larchmt), 2011 Jul 05; 20(10). PMID: 21721934    Free PMC article.
Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.
Priscilla A Furth, M Carla Cabrera, +2 authors, Rebecca E Nakles.
Ann N Y Acad Sci, 2011 Jul 29; 1229. PMID: 21793850    Free PMC article.
Review.
One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens.
Claudius Mueller, Kirsten H Edmiston, +9 authors, Virginia Espina.
PLoS One, 2011 Aug 23; 6(8). PMID: 21858221    Free PMC article.
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Mitch Dowsett, Torsten O Nielsen, +19 authors, International Ki-67 in Breast Cancer Working Group.
J Natl Cancer Inst, 2011 Oct 01; 103(22). PMID: 21960707    Free PMC article.
Highly Cited.
Breast cancer - one term, many entities?
Nicholas R Bertos, Morag Park.
J Clin Invest, 2011 Oct 04; 121(10). PMID: 21965335    Free PMC article.
Highly Cited. Review.
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Anna Marie Mulligan, Fergus J Couch, +187 authors, CIMBA.
Breast Cancer Res, 2011 Nov 08; 13(6). PMID: 22053997    Free PMC article.
Tips and tricks in triple-negative breast cancer: how to manage patients in real-life practice?
M Piccart, G Viale, +2 authors, L Carey.
Ecancermedicalscience, 2012 Jan 26; 5. PMID: 22276059    Free PMC article.
Controversies concerning the use of neoadjuvant systemic therapy for primary breast cancer.
Manfred Kaufmann, Thomas Karn, Eugen Ruckhäberle.
World J Surg, 2012 Jan 27; 36(7). PMID: 22278605
Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.
Farrokh Dehdashti, Richard Laforest, +7 authors, Michael J Welch.
J Nucl Med, 2012 Feb 15; 53(3). PMID: 22331216    Free PMC article.
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, +9 authors, Norman Wolmark.
J Clin Oncol, 2012 Mar 07; 30(12). PMID: 22393101    Free PMC article.
Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides.
Gregory J Metzger, Stephen C Dankbar, +3 authors, Stephen C Schmechel.
PLoS One, 2012 Mar 23; 7(3). PMID: 22438942    Free PMC article.
Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast.
Carolina Sens-Abuázar, Elisa Napolitano E Ferreira, +10 authors, Dirce Maria Carraro.
Transl Oncol, 2012 Apr 13; 5(2). PMID: 22496928    Free PMC article.
Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Amy M Fowler, Szeman Ruby Chan, +8 authors, Michael J Welch.
J Nucl Med, 2012 Jun 07; 53(7). PMID: 22669982    Free PMC article.
Synthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance target.
Jae Hak Lee, Olaf Peters, +7 authors, John A Katzenellenbogen.
Nucl Med Biol, 2012 Jul 04; 39(8). PMID: 22749433    Free PMC article.
Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5.
Allison W Welsh, Malini Harigopal, +2 authors, David L Rimm.
Appl Immunohistochem Mol Morphol, 2012 Jul 24; 21(2). PMID: 22820659    Free PMC article.
Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer.
Nadia Howlader, Anne-Michelle Noone, Mandi Yu, Kathleen A Cronin.
Am J Epidemiol, 2012 Jul 31; 176(4). PMID: 22842721    Free PMC article.
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain.
Renata Duchnowska, Rafał Dziadziuszko, +14 authors, Polish Brain Metastasis Consortium.
Breast Cancer Res, 2012 Aug 18; 14(4). PMID: 22898337    Free PMC article.
Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.
William D Travis, Elisabeth Brambilla, +15 authors, Ming Tsao.
Arch Pathol Lab Med, 2012 Sep 14; 137(5). PMID: 22970842    Free PMC article.
Highly Cited.
Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas.
Shir-Hwa Ueng, Shin-Cheh Chen, +6 authors, Chuen Hsueh.
Int J Clin Exp Pathol, 2012 Oct 17; 5(8). PMID: 23071863    Free PMC article.
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.
Veronique M Neumeister, Valsamo Anagnostou, +7 authors, David L Rimm.
J Natl Cancer Inst, 2012 Oct 24; 104(23). PMID: 23090068    Free PMC article.
High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer.
Yihong Wang, Joseph A Sparano, +4 authors, Hayley M McDaid.
Clin Breast Cancer, 2012 Dec 12; 13(2). PMID: 23218766    Free PMC article.
In human invasive breast ductal carcinoma, tumor stromal macrophages and tumor nest macrophages have distinct relationships with clinicopathological parameters and tumor angiogenesis.
Ewe Seng Ch'ng, Sharifah Emilia Tuan Sharif, Hasnan Jaafar.
Virchows Arch, 2013 Jan 04; 462(3). PMID: 23283409
BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients.
Kiyoshi Takagi, Yasuhiro Miki, +6 authors, Takashi Suzuki.
Horm Cancer, 2013 Jan 05; 4(2). PMID: 23288590
Gene signatures in breast cancer: current and future uses.
Enrique Espinosa Arranz, Juan Ángel Fresno Vara, Angelo Gámez-Pozo, Pilar Zamora.
Transl Oncol, 2013 Jan 17; 5(6). PMID: 23323153    Free PMC article.
Population and target considerations for triple-negative breast cancer clinical trials.
Terry Hyslop, Yvonne Michael, Tiffany Avery, Hallgeir Rui.
Biomark Med, 2013 Feb 08; 7(1). PMID: 23387481    Free PMC article.
Review.
Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors.
Natássia C R Corrêa, Hellen Kuasne, +10 authors, Dawidson A Gomes.
Oncol Rep, 2013 Feb 14; 29(4). PMID: 23404580    Free PMC article.
Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Huiyan Ma, Yani Lu, +11 authors, Leslie Bernstein.
BMC Cancer, 2013 May 07; 13. PMID: 23642215    Free PMC article.
A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events.
Asterios Triantafyllou, Jennifer L Hunt, Kenneth O Devaney, Alfio Ferlito.
Eur Arch Otorhinolaryngol, 2013 May 08; 271(4). PMID: 23649507
Review.
The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.
Nadiyah Kazmi, Diana C Márquez-Garbán, +4 authors, Richard J Pietras.
Lung Cancer Manag, 2013 May 08; 1(4). PMID: 23650476    Free PMC article.
The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence.
Sung Gwe Ahn, Hak Min Lee, +5 authors, Hy-De Lee.
PLoS One, 2013 May 30; 8(5). PMID: 23717438    Free PMC article.
Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
George Pentheroudakis, Vassiliki Kotoula, +19 authors, George Fountzilas.
PLoS One, 2013 Aug 08; 8(7). PMID: 23923010    Free PMC article.
[Gene expression analysis in breast cancer. A new diagnostic tool in pathology].
C Denkert.
Pathologe, 2013 Aug 13; 34(5). PMID: 23934410
Review.
Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer.
António E Pinto, Filipa Areia, +5 authors, Saudade André.
Springerplus, 2013 Sep 07; 2. PMID: 24010033    Free PMC article.
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.
Huiyan Ma, Yani Lu, +11 authors, Leslie Bernstein.
Breast Cancer Res, 2013 Sep 28; 15(5). PMID: 24070170    Free PMC article.
Benefits, issues, and recommendations for personalized medicine in oncology in Canada.
C Butts, S Kamel-Reid, +9 authors, F D Ashbury.
Curr Oncol, 2013 Oct 25; 20(5). PMID: 24155644    Free PMC article.
In situ Protein Detection for Companion Diagnostics.
Gabriela Gremel, Karin Grannas, +2 authors, Agata Zieba.
Front Oncol, 2013 Nov 08; 3. PMID: 24199171    Free PMC article.
Review.
Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness.
Irene Moy, Zhihong Lin, +3 authors, Serdar E Bulun.
PLoS One, 2013 Nov 14; 8(11). PMID: 24223121    Free PMC article.
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
Daniel F Hayes.
BMC Med, 2013 Nov 16; 11. PMID: 24228698    Free PMC article.
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.
C A Purdie, P Quinlan, +4 authors, A M Thompson.
Br J Cancer, 2013 Dec 05; 110(3). PMID: 24300977    Free PMC article.
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study.
Ann E McCullough, Patrizia Dell'orto, +11 authors, Giuseppe Viale.
Breast Cancer Res Treat, 2014 Jan 08; 143(3). PMID: 24395109    Free PMC article.
Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
Laia Domingo, Dolores Salas, +10 authors, INCA Study Group.
Breast Cancer Res, 2014 Jan 15; 16(1). PMID: 24410848    Free PMC article.
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue.
Veronique M Neumeister, Fabio Parisi, +12 authors, David L Rimm.
Lab Invest, 2014 Feb 19; 94(4). PMID: 24535259    Free PMC article.
Recent advances in the molecular characterization of circulating tumor cells.
Lori E Lowes, Alison L Allan.
Cancers (Basel), 2014 Mar 19; 6(1). PMID: 24633084    Free PMC article.
RNAscope for in situ detection of transcriptionally active human papillomavirus in head and neck squamous cell carcinoma.
Hongwei Wang, Mindy Xiao-Ming Wang, +8 authors, Xiao-Jun Ma.
J Vis Exp, 2014 Mar 19; (85). PMID: 24637627    Free PMC article.
HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics.
Beyhan Ataseven, Daniela Gologan, +4 authors, Wolfgang Eiermann.
Breast Care (Basel), 2012 Dec 01; 7(6). PMID: 24715828    Free PMC article.
Review.
Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.
Vandana G Abramson, M Cooper Lloyd, +12 authors, Carlos L Arteaga.
Breast Cancer Res Treat, 2014 Apr 12; 145(2). PMID: 24722917    Free PMC article.
Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy.
Kunpeng Wu, Qiaozhu Yang, +2 authors, Zhixiong Yang.
World J Surg Oncol, 2014 Apr 16; 12. PMID: 24731479    Free PMC article.
miR-221/222 control luminal breast cancer tumor progression by regulating different targets.
Patrizia Dentelli, Matteo Traversa, +10 authors, Maria Felice Brizzi.
Cell Cycle, 2014 Apr 17; 13(11). PMID: 24736554    Free PMC article.
Vascular measurements correlate with estrogen receptor status.
Mark C Lloyd, Khalid O Alfarouk, +5 authors, Robert A Gatenby.
BMC Cancer, 2014 Apr 24; 14. PMID: 24755315    Free PMC article.
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Nadia Howlader, Sean F Altekruse, +4 authors, Kathleen A Cronin.
J Natl Cancer Inst, 2014 Apr 30; 106(5). PMID: 24777111    Free PMC article.
Highly Cited.
GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor.
Kiyoshi Takagi, Takashi Moriguchi, +6 authors, Takashi Suzuki.
Cancer Sci, 2014 May 28; 105(5). PMID: 24862985    Free PMC article.
Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Vincent Richard, Nadège Kindt, +4 authors, Sven Saussez.
Oncol Rep, 2014 Jun 19; 32(2). PMID: 24939415    Free PMC article.
Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.
Mieke Van Bockstal, Kathleen Lambein, +6 authors, Louis Libbrecht.
Virchows Arch, 2014 Jun 30; 465(3). PMID: 24973889
A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.
Oukseub Lee, Katherine Page, +19 authors, Seema A Khan.
Clin Cancer Res, 2014 Jul 17; 20(14). PMID: 25028506    Free PMC article.
Long-term survival analysis of korean breast cancer patients at a single center: improving outcome over time.
Sung Gwe Ahn, Hak Min Lee, +2 authors, Hy-De Lee.
Yonsei Med J, 2014 Jul 23; 55(5). PMID: 25048474    Free PMC article.
Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified?
Damoun Safarpour, Shabnam Pakneshan, Fattaneh A Tavassoli.
Am J Cancer Res, 2014 Jul 25; 4(4). PMID: 25057438    Free PMC article.
Trends and present treatment patterns of early breast cancer in Southwest China.
Qiancheng Hu, Ting Luo, +5 authors, Hong Zheng.
Pathol Oncol Res, 2014 Aug 07; 21(2). PMID: 25096396
Pathogenesis, prevention, diagnosis and treatment of breast cancer.
Rupen Shah, Kelly Rosso, S David Nathanson.
World J Clin Oncol, 2014 Aug 13; 5(3). PMID: 25114845    Free PMC article.
Review.
Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population.
Nataliya Babyshkina, Elena Malinovskaya, +6 authors, Nadejda Cherdyntseva.
Med Oncol, 2014 Aug 21; 31(9). PMID: 25139196
Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients.
Yu-Feng Yang, Ying-Yang Liao, +3 authors, Yan-Fang Xie.
Med Oncol, 2014 Sep 14; 31(10). PMID: 25216864
Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations.
Robynn V Schillace, Amy M Skinner, +5 authors, SuEllen J Pommier.
BMC Cancer, 2014 Oct 02; 14. PMID: 25269750    Free PMC article.
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences.
Mark Kriegsmann, Volker Endris, +8 authors, Wilko Weichert.
Oncotarget, 2014 Oct 10; 5(20). PMID: 25296970    Free PMC article.
Immunohistochemistry of colorectal cancer biomarker phosphorylation requires controlled tissue fixation.
Abbey P Theiss, David Chafin, +2 authors, Geoffrey S Baird.
PLoS One, 2014 Nov 20; 9(11). PMID: 25409462    Free PMC article.
Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.
Debora Fumagalli, Alexis Blanchet-Cohen, +13 authors, Benjamin Haibe-Kains.
BMC Genomics, 2014 Nov 22; 15. PMID: 25412710    Free PMC article.
Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time.
Maria Vassilakopoulou, Fabio Parisi, +7 authors, Veronique M Neumeister.
Lab Invest, 2014 Nov 25; 95(3). PMID: 25418580
Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.
Jeanine Pignatelli, Sumanta Goswami, +10 authors, Maja H Oktay.
Sci Signal, 2014 Nov 28; 7(353). PMID: 25429076    Free PMC article.
Biomarker validation and testing.
Daniel F Hayes.
Mol Oncol, 2014 Dec 03; 9(5). PMID: 25458054    Free PMC article.
Review.
Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
K Kalinsky, J A Mayer, +7 authors, F Z Bischoff.
Clin Transl Oncol, 2015 Jan 24; 17(7). PMID: 25613123    Free PMC article.
Quantum dots for quantitative imaging: from single molecules to tissue.
Tania Q Vu, Wai Yan Lam, Ellen W Hatch, Diane S Lidke.
Cell Tissue Res, 2015 Jan 27; 360(1). PMID: 25620410    Free PMC article.
Review.
Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer.
Rosa Murria, Sarai Palanca, +12 authors, Pascual Bolufer.
Am J Cancer Res, 2015 Jan 30; 5(1). PMID: 25628946    Free PMC article.
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients.
Gul Alco, Atilla Bozdogan, +8 authors, Vahit Ozmen.
Oncol Lett, 2015 Feb 11; 9(3). PMID: 25663855    Free PMC article.
Oxidative stress-mediated apoptosis induced by ethanolic mango seed extract in cultured estrogen receptor positive breast cancer MCF-7 cells.
Al-Shwyeh Hussah Abdullah, Abdulkarim Sabo Mohammed, Abdullah Rasedee, Mohamed Elwathig Saeed Mirghani.
Int J Mol Sci, 2015 Feb 11; 16(2). PMID: 25664859    Free PMC article.
Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues.
Sibylle Gündisch, Laura Annaratone, +6 authors, Gianni Bussolati.
Lab Invest, 2015 Mar 03; 95(5). PMID: 25730369    Free PMC article.
One-Year Neoadjuvant Endocrine Therapy in Breast Cancer.
Orsolya Rusz, András Vörös, +6 authors, Zsuzsanna Kahán.
Pathol Oncol Res, 2015 Mar 11; 21(4). PMID: 25753983
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
Betsy A Kohler, Recinda L Sherman, +11 authors, Lynne Penberthy.
J Natl Cancer Inst, 2015 Apr 01; 107(6). PMID: 25825511    Free PMC article.
Highly Cited.
Optimal systemic therapy for early breast cancer in women: a clinical practice guideline.
A Eisen, G G Fletcher, +5 authors, members of the Early Breast Cancer Systemic Therapy Consensus Panel.
Curr Oncol, 2015 Apr 08; 22(Suppl 1). PMID: 25848340    Free PMC article.
Therapies for triple negative breast cancer.
Eleni Andreopoulou, Sarah J Schweber, Joseph A Sparano, Hayley M McDaid.
Expert Opin Pharmacother, 2015 Apr 18; 16(7). PMID: 25881743    Free PMC article.
Review.
Single-band upconversion nanoprobes for multiplexed simultaneous in situ molecular mapping of cancer biomarkers.
Lei Zhou, Rui Wang, +7 authors, Fan Zhang.
Nat Commun, 2015 Apr 25; 6. PMID: 25907226    Free PMC article.
Defining breast cancer intrinsic subtypes by quantitative receptor expression.
Maggie C U Cheang, Miguel Martin, +21 authors, Lisa A Carey.
Oncologist, 2015 Apr 25; 20(5). PMID: 25908555    Free PMC article.
Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status.
Huiyan Ma, Xinxin Xu, +11 authors, Leslie Bernstein.
Cancer Med, 2015 May 01; 4(7). PMID: 25924995    Free PMC article.
Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score.
Bradley M Turner, Kristin A Skinner, +6 authors, David G Hicks.
Mod Pathol, 2015 May 02; 28(7). PMID: 25932962
A comparison of manual and automated methods of quantitation of oestrogen/progesterone receptor expression in breast carcinoma.
R Vijayashree, P Aruthra, K Ramesh Rao.
J Clin Diagn Res, 2015 May 09; 9(3). PMID: 25954622    Free PMC article.
Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis.
Anna Lisa Tedeschi, Zohreh Eslami, +6 authors, Catalin Mihalcioiu.
Onco Targets Ther, 2015 May 12; 8. PMID: 25960662    Free PMC article.
New breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology images.
Jia-Mei Chen, Ai-Ping Qu, +7 authors, Yan Li.
Sci Rep, 2015 May 30; 5. PMID: 26022540    Free PMC article.
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
Inmaculada de Juan, Sarai Palanca, +25 authors, Pascual Bolufer.
Fam Cancer, 2015 Jun 01; 14(4). PMID: 26026974
Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients.
Piotr Winczura, Katarzyna Sosińska-Mielcarek, +10 authors, Jacek Jassem.
Pathol Oncol Res, 2015 Jun 13; 21(4). PMID: 26062800    Free PMC article.
Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States.
Philip S Rosenberg, Kimberly A Barker, William F Anderson.
J Natl Cancer Inst, 2015 Jun 13; 107(9). PMID: 26063794    Free PMC article.
Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
Yiqian Zhang, Feng Lv, +11 authors, Xiaojing Guo.
PLoS One, 2015 Jun 27; 10(6). PMID: 26115045    Free PMC article.
Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study.
Teresa Pérez, Nikita Makrestsov, +3 authors, Susan Mallett.
Appl Immunohistochem Mol Morphol, 2015 Jul 23; 24(10). PMID: 26200834    Free PMC article.
Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy.
Chi Zhang, Shuang Wang, +7 authors, Eileen P Connolly.
Springerplus, 2015 Aug 05; 4. PMID: 26240784    Free PMC article.
Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis.
Cathrin Brisken, Kathryn Hess, Rachel Jeitziner.
Endocrinology, 2015 Aug 05; 156(10). PMID: 26241069    Free PMC article.
Review.
Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients.
Wen-Kai Ge, Ben Yang, +5 authors, Mei-Zhu Zheng.
Thorac Cancer, 2015 Aug 15; 6(1). PMID: 26273337    Free PMC article.
Organochlorine insecticides DDT and chlordane in relation to survival following breast cancer.
Humberto Parada, Mary S Wolff, +7 authors, Marilie D Gammon.
Int J Cancer, 2015 Aug 19; 138(3). PMID: 26285160    Free PMC article.
Molecular heterogeneity in adjacent cells in triple-negative breast cancer.
Michael L Huebschman, Nancy L Lane, +3 authors, Eugene P Frenkel.
Breast Cancer (Dove Med Press), 2015 Sep 01; 7. PMID: 26316815    Free PMC article.
Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.
Erin K Shanle, Adedayo A Onitilo, +5 authors, Kari B Wisinski.
Am J Transl Res, 2015 Sep 04; 7(7). PMID: 26328009    Free PMC article.
Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine.
Rosa Murria, Sarai Palanca, +14 authors, Pascual Bolufer.
Am J Cancer Res, 2015 Sep 04; 5(7). PMID: 26328265    Free PMC article.
Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor.
Hiroyuki Minemura, Kiyoshi Takagi, +7 authors, Takashi Suzuki.
Cancer Sci, 2015 Sep 04; 106(11). PMID: 26331797    Free PMC article.
Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast Cancer.
Young Kyung Bae, Jung Eun Choi, Su Hwan Kang, Soo Jung Lee.
J Breast Cancer, 2015 Oct 17; 18(3). PMID: 26472976    Free PMC article.
St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.
M Soares, J Correia, M C Peleteiro, F Ferreira.
Tumour Biol, 2015 Oct 22; 37(3). PMID: 26486327
The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysis.
Jieqiong Liu, Kai Chen, +3 authors, Lisa K Jacobs.
Oncotarget, 2015 Oct 31; 7(5). PMID: 26515602    Free PMC article.
Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.
Soo Young Chung, Yoon Yang Jung, +12 authors, Han Suk Ryu.
Clin Exp Metastasis, 2015 Nov 21; 33(2). PMID: 26585892
Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer.
Gabrielle M Baker, Tiffany Murphy, +2 authors, Frank J Lynch.
Cancer Manag Res, 2015 Dec 18; 7. PMID: 26673410    Free PMC article.
Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.
Kyueng-Whan Min, Dong-Hoon Kim, +14 authors, Kyoung Min Moon.
Virchows Arch, 2016 Jan 01; 468(4). PMID: 26719157
Application of the 2013 ASCO/CAP guideline and the SISH technique for HER2 testing of breast cancer selects more patients for anti-HER2 treatment.
António Polónia, Dina Leitão, Fernando Schmitt.
Virchows Arch, 2016 Jan 13; 468(4). PMID: 26754674
Polychlorinated biphenyls and their association with survival following breast cancer.
Humberto Parada, Mary S Wolff, +5 authors, Marilie D Gammon.
Eur J Cancer, 2016 Jan 23; 56. PMID: 26798968    Free PMC article.
Impact of Breast Cancer Subtype Defined by Immunohistochemistry Hormone Receptor and HER2 Status on the Incidence of Immediate Postmastectomy Reconstruction.
Wei Wu, Shi Cheng, +3 authors, Minghui Cao.
Medicine (Baltimore), 2016 Jan 29; 95(3). PMID: 26817902    Free PMC article.
Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.
Amy M Fowler, Amy S Clark, +2 authors, Farrokh Dehdashti.
J Nucl Med, 2016 Feb 03; 57 Suppl 1. PMID: 26834106    Free PMC article.
Review.
Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.
Maria Soares, Rita Ribeiro, +4 authors, Fernando Ferreira.
Oncotarget, 2016 Feb 26; 7(14). PMID: 26909614    Free PMC article.
Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians.
Sherine M Rizk, Nancy N Shahin, Olfat G Shaker.
PLoS One, 2016 Mar 22; 11(3). PMID: 26999517    Free PMC article.
Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Janice S Sung, Sarah Stamler, +6 authors, Christopher E Comstock.
Radiology, 2016 Apr 21; 280(3). PMID: 27097237    Free PMC article.
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism.
Anup Sood, Alexandra M Miller, +15 authors, Ingo K Mellinghoff.
JCI Insight, 2016 May 18; 1(6). PMID: 27182557    Free PMC article.
Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Yi Chen, Kai Chen, +5 authors, Erwei Song.
BMC Cancer, 2016 May 21; 16. PMID: 27198767    Free PMC article.
Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Li Zhang, Yansheng Wu, +2 authors, Zhongsheng Tong.
Oncotarget, 2016 May 26; 7(32). PMID: 27223440    Free PMC article.
The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen.
Nataliya Babyshkina, Sergey Vtorushin, +7 authors, Evgeny Choynzonov.
Clin Exp Med, 2016 May 27; 17(3). PMID: 27225751
Approach to the Triple Negative Breast Cancer in New Drugs Area.
Mehrzad Mirzania.
Int J Hematol Oncol Stem Cell Res, 2016 Jun 03; 10(2). PMID: 27252813    Free PMC article.
Review.
Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer.
Ke Su, Pengchao Hu, +7 authors, Jingwei Zhang.
Oncotarget, 2016 Jun 21; 7(29). PMID: 27322681    Free PMC article.
TACC2 (transforming acidic coiled-coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation.
Yoshiaki Onodera, Kiyoshi Takagi, +7 authors, Takashi Suzuki.
Cancer Med, 2016 Jun 24; 5(8). PMID: 27333920    Free PMC article.
Hornerin Is Involved in Breast Cancer Progression.
Jinhyuk Choi, Dong-Il Kim, +2 authors, Aeree Kim.
J Breast Cancer, 2016 Jul 07; 19(2). PMID: 27382389    Free PMC article.
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Mark Laible, Kornelia Schlombs, +8 authors, Ugur Sahin.
BMC Cancer, 2016 Jul 09; 16. PMID: 27389414    Free PMC article.
Operation with less adjuvant therapy for elderly breast cancer.
Akimitsu Yamada, Kazutaka Narui, +5 authors, Itaru Endo.
J Surg Res, 2016 Aug 28; 204(2). PMID: 27565077    Free PMC article.
Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.
Wenlian Zhu, Susan Harvey, +2 authors, Dmitri Artemov.
Clin Breast Cancer, 2016 Aug 29; 17(1). PMID: 27568102    Free PMC article.
Multiplexed imaging reveals heterogeneity of PI3K/MAPK network signaling in breast lesions of known PIK3CA genotype.
Thomas Jacob, Joe W Gray, Megan Troxell, Tania Q Vu.
Breast Cancer Res Treat, 2016 Sep 02; 159(3). PMID: 27581127    Free PMC article.
CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
Hiroyuki Minemura, Kiyoshi Takagi, +7 authors, Takashi Suzuki.
Cancer Sci, 2016 Sep 15; 107(12). PMID: 27627783    Free PMC article.
Decoding the usefulness of non-coding RNAs as breast cancer markers.
Maria Amorim, Sofia Salta, Rui Henrique, Carmen Jerónimo.
J Transl Med, 2016 Sep 16; 14. PMID: 27629831    Free PMC article.
Review.
Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.
Jieqiong Liu, Kai Chen, +5 authors, Lisa K Jacobs.
J Cancer Res Clin Oncol, 2016 Oct 06; 143(1). PMID: 27704268
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.
A Hennigs, F Riedel, +9 authors, A Schneeweiss.
Breast Cancer Res Treat, 2016 Nov 03; 160(3). PMID: 27744486    Free PMC article.
Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
Eva Jezkova, Karol Kajo, +7 authors, Jan Danko.
Tumour Biol, 2016 Nov 03;. PMID: 27744628
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
Sophia Frentzas, Eve Simoneau, +28 authors, Andrew R Reynolds.
Nat Med, 2016 Nov 01; 22(11). PMID: 27748747    Free PMC article.
Highly Cited.
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation.
Pascal Gellert, Corrinne V Segal, +23 authors, POETIC Trial Management Group and Trialists.
Nat Commun, 2016 Nov 09; 7. PMID: 27827358    Free PMC article.
A nomogram to predict the probability of axillary lymph node metastasis in female patients with breast cancer in China: A nationwide, multicenter, 10-year epidemiological study.
Jian Zhang, Xiao Li, +13 authors, Ke Wang.
Oncotarget, 2016 Nov 17; 8(21). PMID: 27852049    Free PMC article.
Application of the downgrade criteria to supplemental screening ultrasound for women with negative mammography but dense breasts.
Soo-Yeon Kim, Min Jung Kim, +2 authors, Eun-Kyung Kim.
Medicine (Baltimore), 2016 Nov 20; 95(44). PMID: 27858896    Free PMC article.
Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Victoria L Bridgeman, Peter B Vermeulen, +19 authors, Andrew R Reynolds.
J Pathol, 2016 Nov 20; 241(3). PMID: 27859259    Free PMC article.
Highly Cited.
Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.
Tânia Filipa S Mendes, Leon D Kluskens, Lígia Raquel Rodrigues.
Adv Sci (Weinh), 2015 Jul 17; 2(11). PMID: 27980912    Free PMC article.
Comment to "Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis".
Kadri Altundag.
J Breast Cancer, 2017 Jan 06; 19(4). PMID: 28053637    Free PMC article.
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.
Angela N Bartley, Mary Kay Washington, +12 authors, Jaffer A Ajani.
Am J Clin Pathol, 2017 Jan 13; 146(6). PMID: 28077399    Free PMC article.
Systematic Review.
Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
Huiyan Ma, Giske Ursin, +13 authors, Leslie Bernstein.
Breast Cancer Res, 2017 Jan 15; 19(1). PMID: 28086982    Free PMC article.
Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting.
Agnieszka Adamczyk, Aleksandra Grela-Wojewoda, +8 authors, Joanna Niemiec.
J Cancer, 2017 Jan 27; 8(1). PMID: 28123607    Free PMC article.
Prognostic value of follistatin-like 3 in human invasive breast cancer.
Henrique L Couto, Marcelo A Buzelin, +3 authors, Fernando M Reis.
Oncotarget, 2017 Feb 09; 8(26). PMID: 28178680    Free PMC article.
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.
Onofrio Antonio Catalano, Gary Lloyd Horn, +11 authors, Bruce Robert Rosen.
Br J Cancer, 2017 Feb 17; 116(7). PMID: 28208155    Free PMC article.
BCL6 mRNA Expression Level in Invasive Duct Carcinoma not otherwise Specified.
Eman Badr, Eman Masoud, Asmaa Gaber Abdou, Marwa Serag Eldien.
J Clin Diagn Res, 2017 Feb 18; 10(12). PMID: 28208987    Free PMC article.
Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.
J Xu, C Ni, +5 authors, X Qu.
Clin Transl Oncol, 2017 Mar 02; 19(8). PMID: 28247194
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, +15 authors, Henrik Lindman.
JAMA Oncol, 2017 Mar 03; 3(6). PMID: 28253390    Free PMC article.
Aptahistochemistry in diagnostic pathology: technical scrutiny and feasibility.
Bakhtiar A Bukari, Marimuthu Citartan, +3 authors, Thean-Hock Tang.
Histochem Cell Biol, 2017 Mar 23; 147(5). PMID: 28321500
Review.
Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.
Joanna A Niemiec, Agnieszka Adamczyk, +10 authors, Beata Sas-Korczyńska.
Am J Transl Res, 2017 Apr 08; 9(3). PMID: 28386369    Free PMC article.
Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis.
Mayuko Chishiki, Kiyoshi Takagi, +8 authors, Takashi Suzuki.
Cancer Sci, 2017 Apr 11; 108(7). PMID: 28394473    Free PMC article.
A Comprehensive Model for Predicting Recurrence and Survival in Cases of Chinese Postoperative Invasive Breast Cancer
Xianhe Xie, Yanfen Hu, +7 authors, Weili Zheng.
Asian Pac J Cancer Prev, 2017 Apr 27; 18(3). PMID: 28441706    Free PMC article.
Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status.
Kai Mao, Yaping Yang, +3 authors, Jieqiong Liu.
PLoS One, 2017 May 04; 12(5). PMID: 28467490    Free PMC article.
Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.
Gábor Cserni, Giuseppe Floris, +5 authors, Zsuzsanna Varga.
Virchows Arch, 2017 May 22; 471(1). PMID: 28528509
Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
Gregor Krings, Nancy M Joseph, +12 authors, Yunn-Yi Chen.
Mod Pathol, 2017 May 27; 30(8). PMID: 28548128
Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.
Kathleen Lambein, Mieke Van Bockstal, +5 authors, Louis Libbrecht.
Virchows Arch, 2017 Jun 02; 471(5). PMID: 28567637
Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?
Vincent Richard, Raphaël Conotte, David Mayne, Jean-Marie Colet.
Oncotarget, 2017 Jun 15; 8(30). PMID: 28611296    Free PMC article.
Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer.
Yong-Il Kim, Yong Joong Kim, +4 authors, Keon Wook Kang.
Eur J Nucl Med Mol Imaging, 2017 Jun 16; 44(11). PMID: 28616695
Characterization of HER2 gene amplification heterogeneity in invasive and in situ breast cancer using bright-field in situ hybridization.
António Polónia, Guilherme Oliveira, Fernando Schmitt.
Virchows Arch, 2017 Jul 14; 471(5). PMID: 28702778
Development of a Breast Cancer Treatment Program in Port-au-Prince, Haiti: Experiences From the Field.
Vincent DeGennaro, Rachel Libby, +8 authors, Judith Hurley.
J Glob Oncol, 2015 Oct 28; 2(1). PMID: 28717677    Free PMC article.
Long-term remission of hormone receptor-positive/HER2-positive metastatic breast cancer due to combined treatment with everolimus/trastuzumab/exemestane: A case report.
Jian Wang, Chunxiao Sun, +2 authors, Yongmei Yin.
Oncol Lett, 2017 Aug 10; 14(2). PMID: 28789401    Free PMC article.
The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.
O Burgués, Mª Á López-García, +4 authors, V Peg.
Clin Transl Oncol, 2017 Aug 11; 20(3). PMID: 28795336
Estrogen receptor (ESR1) mutation in bone metastases from breast cancer.
Stephan Bartels, Matthias Christgen, +4 authors, Hans Kreipe.
Mod Pathol, 2017 Aug 12; 31(1). PMID: 28799536
Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach?
Pavol Zubor, Alexandra Gondova, +4 authors, Olga Golubnitschaja.
EPMA J, 2017 Aug 22; 8(2). PMID: 28824738    Free PMC article.
Estrogen receptor quantitative measures and breast cancer survival.
Deirdre A Hill, Marc Barry, +4 authors, Lesley Lomo.
Breast Cancer Res Treat, 2017 Aug 22; 166(3). PMID: 28825224    Free PMC article.
Adaptive Multiview Nonnegative Matrix Factorization Algorithm for Integration of Multimodal Biomedical Data.
Bisakha Ray, Wenke Liu, David Fenyö.
Cancer Inform, 2017 Aug 25; 16. PMID: 28835735    Free PMC article.
Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer.
Hany A Abdel-Hafiz.
Diseases, 2017 Sep 22; 5(3). PMID: 28933369    Free PMC article.
Review.
Awareness and current knowledge of breast cancer.
Muhammad Akram, Mehwish Iqbal, Muhammad Daniyal, Asmat Ullah Khan.
Biol Res, 2017 Oct 04; 50(1). PMID: 28969709    Free PMC article.
Highly Cited. Review.
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.
Alfonso Sánchez-Muñoz, Luis Vicioso, +12 authors, Emilio Alba.
Mod Pathol, 2017 Oct 07; 31(2). PMID: 28984296
Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.
Akanksha S Mahajan, Bruna M Sugita, +8 authors, Luciane R Cavalli.
PLoS One, 2017 Oct 20; 12(10). PMID: 29049316    Free PMC article.
Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay.
Michaela Tsai, Shelly Lo, +11 authors, Hatem Soliman.
JAMA Oncol, 2017 Oct 28; 4(1). PMID: 29075751    Free PMC article.
Molecular Subtypes and Local-Regional Control of Breast Cancer.
Simona Maria Fragomeni, Andrew Sciallis, Jacqueline S Jeruss.
Surg Oncol Clin N Am, 2017 Nov 15; 27(1). PMID: 29132568    Free PMC article.
Review.
A tissue microRNA signature that predicts the prognosis of breast cancer in young women.
Ai Hironaka-Mitsuhashi, Juntaro Matsuzaki, +10 authors, Takahiro Ochiya.
PLoS One, 2017 Nov 16; 12(11). PMID: 29141042    Free PMC article.
The crossroads of breast cancer progression: insights into the modulation of major signaling pathways.
Fernando J Velloso, Arthur Fr Bianco, +8 authors, Ricardo G Correa.
Onco Targets Ther, 2017 Dec 05; 10. PMID: 29200866    Free PMC article.
Review.
Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Prihantono Prihantono, Mochammad Hatta, +5 authors, Andi Nilawati Usman.
J Oncol, 2017 Dec 12; 2017. PMID: 29225623    Free PMC article.
Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity.
S M Reddy, C H Barcenas, +5 authors, V Valero.
Br J Cancer, 2017 Dec 14; 118(1). PMID: 29235566    Free PMC article.
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
R Colomer, I Aranda-López, +7 authors, J Palacios-Calvo.
Clin Transl Oncol, 2017 Dec 24; 20(7). PMID: 29273958    Free PMC article.
Review.
Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.
J Mark Elwood, Sandar Tin Tin, +2 authors, Ian Campbell.
BMC Cancer, 2018 Jan 18; 18(1). PMID: 29334917    Free PMC article.
Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
Huiyan Ma, Giske Ursin, +12 authors, Leslie Bernstein.
Breast Cancer Res, 2018 Jan 24; 20(1). PMID: 29357906    Free PMC article.
Molecular Subtypes of Indonesian Breast Carcinomas - Lack of Association with Patient Age and Tumor Size
Yeni Rahmawati, Yunita Setyawati, +2 authors, Dewajani Purnomosari.
Asian Pac J Cancer Prev, 2018 Jan 28; 19(1). PMID: 29373908    Free PMC article.
Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
Soo-Yeon Kim, Nariya Cho, +8 authors, Woo Kyung Moon.
Eur Radiol, 2018 Jan 31; 28(7). PMID: 29380033
Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells.
Qiang Wang, Jun Jiang, +23 authors, Xiu-Wu Bian.
Cell Res, 2018 Feb 03; 28(3). PMID: 29393296    Free PMC article.
Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge.
Yehoda M Martei, Lydia E Pace, Jane E Brock, Lawrence N Shulman.
Clin Lab Med, 2018 Feb 08; 38(1). PMID: 29412880    Free PMC article.
Review.
Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms.
Qi Fang, Shuang Yao, Guanghua Luo, Xiaoying Zhang.
Oncotarget, 2018 Feb 09; 9(2). PMID: 29416786    Free PMC article.
Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients.
Rui Chen, Yin Ye, +9 authors, Shengchun Liu.
Breast Cancer Res Treat, 2018 Feb 27; 170(1). PMID: 29480449    Free PMC article.
Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer
Abeer Ismail, Rehab El-Awady, +2 authors, Shimaa Shwaki Ramadan.
Asian Pac J Cancer Prev, 2018 Feb 27; 19(2). PMID: 29481024    Free PMC article.
ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens.
Kiyoshi Takagi, Yasuhiro Miki, +4 authors, Takashi Suzuki.
Int J Mol Sci, 2018 Mar 15; 19(3). PMID: 29534468    Free PMC article.
Association between enhancement patterns and parameters of contrast-enhanced ultrasound and microvessel distribution in breast cancer.
Xiaokang Li, Yaqing Li, +2 authors, Peifang Liu.
Oncol Lett, 2018 Mar 21; 15(4). PMID: 29556301    Free PMC article.
Analysis of membranous Ki-67 staining in breast cancer and surrounding breast epithelium.
Gábor Cserni.
Virchows Arch, 2018 Mar 30; 473(2). PMID: 29594352
Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.
Neal Shah, Afroz S Mohammad, +9 authors, Paul R Lockman.
Pharmacol Res, 2018 Apr 01; 132. PMID: 29604436    Free PMC article.
Review.
Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry.
Sang Yull Kang, Yoo Seok Kim, +5 authors, Korean Breast Cancer Society.
J Breast Cancer, 2018 Apr 10; 21(1). PMID: 29628978    Free PMC article.
Review.
Urinary Phthalate Metabolite Concentrations and Breast Cancer Incidence and Survival following Breast Cancer: The Long Island Breast Cancer Study Project.
Humberto Parada, Marilie D Gammon, +5 authors, Susan L Teitelbaum.
Environ Health Perspect, 2018 Apr 28; 126(4). PMID: 29701940    Free PMC article.
Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.
Ya-Xuan Liu, Ke-Jing Zhang, Li-Li Tang.
Oncol Lett, 2018 May 31; 15(6). PMID: 29844843    Free PMC article.
Validity of Administrative Databases in Comparison to Medical Charts for Breast Cancer Treatment Data.
Ashini Weerasinghe, Courtney R Smith, +16 authors, Anna M Chiarelli.
J Cancer Epidemiol, 2018 Jun 05; 2018. PMID: 29861727    Free PMC article.
Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population.
Atif Ali Hashmi, Samreen Naz, +6 authors, Muhammad Muzzammil Edhi.
BMC Res Notes, 2018 Jun 10; 11(1). PMID: 29884220    Free PMC article.
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy.
Angela Santonja, Alfonso Sánchez-Muñoz, +18 authors, Emilio Alba.
Oncotarget, 2018 Jun 15; 9(41). PMID: 29899867    Free PMC article.
CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.
Alda Losi Guembarovski, Roberta Losi Guembarovski, +5 authors, Edna Maria Vissoci Reiche.
Mol Biol Rep, 2018 Jun 22; 45(5). PMID: 29926386
Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.
K Uhr, A M Sieuwerts, +4 authors, J W M Martens.
Sci Rep, 2018 Jun 27; 8(1). PMID: 29941867    Free PMC article.
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes.
Franziska Würfel, Ramona Erber, +22 authors, Matthias Rübner.
Breast Care (Basel), 2018 Jun 29; 13(1). PMID: 29950961    Free PMC article.
Recent Advances in the Treatment of Breast Cancer.
Christy W S Tong, Mingxia Wu, William C S Cho, Kenneth K W To.
Front Oncol, 2018 Jul 03; 8. PMID: 29963498    Free PMC article.
Highly Cited. Review.
MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer.
Mustafa Kahraman, Anne Röske, +15 authors, Michael G Schrauder.
Sci Rep, 2018 Aug 04; 8(1). PMID: 30072748    Free PMC article.
The Effect of Perioperative Bevacizumab on Disease-Free and Overall Survival in Locally Advanced HER-2 Negative Breast Cancer: A Meta-Analysis.
Yanal Alnimer, Zakaria Hindi, Khalil Katato.
Breast Cancer (Auckl), 2018 Aug 10; 12. PMID: 30090017    Free PMC article.
Review.
OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma.
Akifumi Mayama, Kiyoshi Takagi, +10 authors, Takashi Suzuki.
Cancer Sci, 2018 Aug 24; 109(10). PMID: 30137688    Free PMC article.
A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown BRCA Mutation Status.
Ying-Wen Su, Chia-Yen Hung, +2 authors, Po-Sheng Yang.
Clin Med Insights Oncol, 2018 Aug 29; 12. PMID: 30150877    Free PMC article.
Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
J Mark Elwood, Essa Tawfiq, +5 authors, Ross Lawrenson.
BMC Cancer, 2018 Sep 19; 18(1). PMID: 30223800    Free PMC article.
Epidemiological, Clinical, and Histopathological Features of Breast Cancer in Haiti.
Vincent DeGennaro, Faiz Jiwani, +6 authors, Joseph Bernard.
J Glob Oncol, 2018 Sep 23; 4. PMID: 30241242    Free PMC article.
High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer.
Sun Hee Kang, Jihyoung Cho, Hasong Jeong, Sun Young Kwon.
J Breast Cancer, 2018 Oct 03; 21(3). PMID: 30275857    Free PMC article.
Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer.
Atif Ali Hashmi, Samreen Naz, +6 authors, Muhammad Muzzammil Edhi.
BMC Clin Pathol, 2018 Oct 12; 18. PMID: 30305801    Free PMC article.
Status of FAS and FAS Ligand Gene Polymorphisms in Patients with Breast Cancer in Northeastern IRAN.
Seyed Amir Jalali, Fatemeh Homaei Shandiz, +3 authors, Mojgan Mohammadi.
Rep Biochem Mol Biol, 2018 Oct 17; 7(1). PMID: 30324114    Free PMC article.
68Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer.
Quetzali Gabriela Pitalúa-Cortés, Francisco O García-Pérez, +8 authors, Isabel Sollozo-Dupont.
BJR Case Rep, 2017 May 06; 3(3). PMID: 30363270    Free PMC article.
Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells.
Soni Khandelwal, Mallory Boylan, Julian E Spallholz, Lauren Gollahon.
Int J Mol Sci, 2018 Oct 31; 19(11). PMID: 30373175    Free PMC article.
Immunocytochemistry using Liquid-based Cytology: A Tool in Hormone Receptor Analysis of Breast Cancer.
Kalpalata Tripathy, Aparajita Mishra, +3 authors, Anusaya Lenka.
J Cytol, 2018 Dec 01; 35(4). PMID: 30498302    Free PMC article.
A novel role of kynureninase in the growth control of breast cancer cells and its relationships with breast cancer.
Yingzhe Liu, Xueping Feng, +6 authors, Yongzhi Xiao.
J Cell Mol Med, 2019 Jul 25; 23(10). PMID: 31332944    Free PMC article.
Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection.
Narittee Sukswai, Joseph D Khoury.
Curr Hematol Malig Rep, 2019 Jul 25; 14(5). PMID: 31338668
Review.
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
Hannah Deborah Müller, Florian Posch, +9 authors, Marija Balic.
Ann Surg Oncol, 2019 Aug 28; 26(13). PMID: 31452052    Free PMC article.
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform.
Yoon-Sim Yap, Man Chun Leong, +13 authors, Darren Wan-Teck Lim.
PLoS One, 2019 Sep 26; 14(9). PMID: 31553731    Free PMC article.
Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer.
Nataliya Babyshkina, Sergey Vtorushin, +5 authors, Evgeny Choynzonov.
Clin Exp Med, 2019 Sep 29; 19(4). PMID: 31562548
Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer.
Marie Joelle Jabagi, Anthony Goncalves, +3 authors, Rosemary Dray-Spira.
Cancers (Basel), 2019 Oct 02; 11(10). PMID: 31569513    Free PMC article.
Evaluations of Biomarker Status Changes between Primary and Recurrent Tumor Tissue Samples in Breast Cancer Patients.
Thi Hoa Nguyen, Van Hung Nguyen, +2 authors, Thi Huyen Phung.
Biomed Res Int, 2019 Oct 05; 2019. PMID: 31583246    Free PMC article.
Suboptimal concordance in testing and retesting results of triple-negative breast carcinoma cases among laboratories: one institution experience.
Jose De Jesus, Marilin Rosa.
Cancer Cell Int, 2019 Oct 22; 19. PMID: 31632197    Free PMC article.
Two Distinct Subtypes Revealed in Blood Transcriptome of Breast Cancer Patients With an Unsupervised Analysis.
Wenlong Ming, Hui Xie, +7 authors, Wanjun Gu.
Front Oncol, 2019 Oct 22; 9. PMID: 31632916    Free PMC article.
IHC Color Histograms for Unsupervised Ki67 Proliferation Index Calculation.
Rokshana S Geread, Peter Morreale, +4 authors, April Khademi.
Front Bioeng Biotechnol, 2019 Oct 22; 7. PMID: 31632956    Free PMC article.
Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study.
Deirdre A Hill, Eric R Prossnitz, Melanie Royce, Andrea Nibbe.
PLoS One, 2019 Oct 28; 14(10). PMID: 31647839    Free PMC article.
Report of clinico-pathological features of breast cancer in HIV-infected and uninfected women in Botswana.
Rohini K Bhatia, Mohan Narasimhamurthy, +8 authors, Surbhi Grover.
Infect Agent Cancer, 2019 Oct 28; 14. PMID: 31649747    Free PMC article.
Clinical significance of serum PSA in breast cancer patients.
Toru Hanamura, Koichi Ohno, +7 authors, Ken-Ichi Ito.
BMC Cancer, 2019 Oct 31; 19(1). PMID: 31664946    Free PMC article.
Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications.
Ana Godoy-Ortiz, Alfonso Sanchez-Muñoz, +4 authors, Emilio Alba.
Front Oncol, 2019 Nov 19; 9. PMID: 31737566    Free PMC article.
Review.
Subtypes of Breast Cancer in Lao P.D.R.: A Study in a Limited-Resource Setting
Thitsamay Luangxay, Siriphone Virachith, +8 authors, Motoji Sawabe.
Asian Pac J Cancer Prev, 2019 Feb 26; 20(2). PMID: 30806064    Free PMC article.
Luminal B is the Most Common Intrinsic Molecular Subtypes of Invasive Ductal Breast Carcinoma Patients in East Kalimantan, Indonesia.
Swandari Paramita, Eko Nugroho Raharjo, +2 authors, Nur Ahlina Hanifah.
Asian Pac J Cancer Prev, 2019 Aug 28; 20(8). PMID: 31450891    Free PMC article.
Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes.
Laia Domingo, Maria Sala, +7 authors, Camiss Study Group.
J Oncol, 2019 Dec 31; 2019. PMID: 31885567    Free PMC article.
LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients.
Sung Gwe Ahn, Seung Myung Dong, +9 authors, Jeffrey E Green.
Breast Cancer Res Treat, 2013 Aug 13; 141(1). PMID: 23933800    Free PMC article.
Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
Jiwon Koh, Keun-Wook Lee, +7 authors, Hye Seung Lee.
Oncologist, 2019 Aug 03; 24(12). PMID: 31371521    Free PMC article.
Unravelling the role of long non-coding RNA - LINC01087 in breast cancer.
Rashmi Tripathi, Imlimaong Aier, Pavan Chakraborty, Pritish Kumar Varadwaj.
Noncoding RNA Res, 2020 Jan 29; 5(1). PMID: 31989062    Free PMC article.
Nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy.
Lihua Zheng, Feng Liu, +2 authors, Yunjiang Liu.
Medicine (Baltimore), 2019 Dec 27; 98(52). PMID: 31876745    Free PMC article.
Comparison of wait times across the breast cancer treatment pathway among screened women undergoing organized breast assessment versus usual care.
Kristina M Blackmore, Ashini Weerasinghe, +17 authors, Anna M Chiarelli.
Can J Public Health, 2019 May 01; 110(5). PMID: 31037608    Free PMC article.
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy.
Carmine De Angelis, Chandandeep Nagi, +22 authors, Rachel Schiff.
Clin Cancer Res, 2019 Oct 28; 26(3). PMID: 31653641    Free PMC article.
ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway.
Guangliang Li, Jing Zhang, Zhenzhen Xu, Zhongqi Li.
Cancer Manag Res, 2020 Feb 06; 12. PMID: 32021441    Free PMC article.
Structural Studies of Epithelial Mesenchymal Transition Breast Tissues.
S N Mohd Sobri, S F Abdul Sani, +5 authors, D A Bradley.
Sci Rep, 2020 Feb 08; 10(1). PMID: 32029810    Free PMC article.
Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Anna M Chiarelli, Kristina M Blackmore, +7 authors, Ellen Warner.
J Natl Cancer Inst, 2019 Jun 25; 112(2). PMID: 31233143    Free PMC article.
Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells.
Hongmei Chen, Xiuxiu Cong, +16 authors, Tianmeng Sun.
Sci Adv, 2020 Feb 18; 6(5). PMID: 32064335    Free PMC article.
Prognostic Utility of Cyclin D1 in Invasive Breast Carcinoma.
Tamanna Parvin, Chhanda Das, +2 authors, Madhumita Mukhopadhyay.
Indian J Surg Oncol, 2019 Apr 06; 10(1). PMID: 30948894    Free PMC article.
Association between serum and adipose tissue resistin with dysglycemia in South Asian women.
Sulochana Wijetunge, R M C J Ratnayake, +5 authors, Nishan Sudheera Kalupahana.
Nutr Diabetes, 2019 Feb 20; 9(1). PMID: 30778042    Free PMC article.
Expression of Estrogen-Related Receptors in Localized Provoked Vulvodynia.
Anu Aalto, Riitta Huotari-Orava, +2 authors, Synnöve Staff.
Biores Open Access, 2020 Mar 03; 9(1). PMID: 32117596    Free PMC article.
Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.
Meghan J Walker, Lucia Mirea, +6 authors, Anna M Chiarelli.
Fam Cancer, 2013 Oct 08; 13(2). PMID: 24097051
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.
Pedram Razavi, Matthew T Chang, +42 authors, José Baselga.
Cancer Cell, 2018 Sep 12; 34(3). PMID: 30205045    Free PMC article.
Highly Cited.
Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b.
Cameron E Snell, Madeline Gough, +7 authors, Wayne D Tilley.
Br J Cancer, 2018 Nov 10; 119(11). PMID: 30410061    Free PMC article.
Bovine leukemia virus DNA associated with breast cancer in women from South Brazil.
Daniela Schwingel, Ana P Andreolla, +2 authors, Luiz C Kreutz.
Sci Rep, 2019 Mar 01; 9(1). PMID: 30814631    Free PMC article.
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.
Mustapha Abubakar, Jonine Figueroa, +8 authors, Paul D Pharoah.
Mod Pathol, 2019 Apr 13; 32(9). PMID: 30976105    Free PMC article.
A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Ah Young Park, Myoungae Kwon, +8 authors, Bo Kyoung Seo.
Korean J Radiol, 2019 Apr 18; 20(5). PMID: 30993927    Free PMC article.
Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system.
Esther C Yoon, Christopher Schwartz, +3 authors, Farbod Darvishian.
Breast J, 2019 Jun 15; 25(5). PMID: 31197914    Free PMC article.
Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis.
Liubov A Tashireva, Marina V Zavyalova, +4 authors, Vladimir M Perelmuter.
Front Oncol, 2020 Mar 11; 10. PMID: 32154161    Free PMC article.
De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis.
Li Zhang, Zhijun Li, +3 authors, Zhongsheng Tong.
Oncol Lett, 2020 Mar 29; 19(4). PMID: 32218843    Free PMC article.
Introduction to digital pathology and computer-aided pathology.
Soojeong Nam, Yosep Chong, +5 authors, Heounjeong Go.
J Pathol Transl Med, 2020 Feb 13; 54(2). PMID: 32045965    Free PMC article.
Review.
Differentiation of Breast Lesions and Distinguishing Their Histological Subtypes Using Diffusion-Weighted Imaging and ADC Values.
Jelena Maric, Jasmina Boban, +3 authors, Dragana Bogdanovic-Stojanovic.
Front Oncol, 2020 Apr 02; 10. PMID: 32232007    Free PMC article.
Establishing benchmarks and metrics for disruptive technologies, inappropriate and obsolete tests in the clinical laboratory.
Frederick L Kiechle, Rodney C Arcenas, Linda C Rogers.
Clin Chim Acta, 2013 Jun 05; 427. PMID: 23732401    Free PMC article.
Review.
Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer.
Chao Ni, Yimin Shen, +5 authors, Yajuan Zheng.
Cancer Med, 2020 Feb 06; 9(7). PMID: 32017443    Free PMC article.
Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification.
Mieke R Van Bockstal, Marie Colombe Agahozo, +7 authors, Carolien H M van Deurzen.
Mol Oncol, 2020 Feb 15; 14(4). PMID: 32058674    Free PMC article.
Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer.
Amy M Fowler, Kelley Salem, +6 authors, Aparna M Mahajan.
Horm Cancer, 2020 Jan 17; 11(2). PMID: 31942683    Free PMC article.
Comprehensive analyses with radiological and biological markers of breast cancer on contrast-enhanced chest CT: a single center experience using dual-layer spectral detector CT.
Jin Il Moon, Bo Hwa Choi, +6 authors, Hyo Jung An.
Eur Radiol, 2020 Feb 07; 30(5). PMID: 32025829
Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement.
Soo Yeon Kim, Nariya Cho, +5 authors, Woo Kyung Moon.
Korean J Radiol, 2020 Apr 24; 21(5). PMID: 32323501    Free PMC article.
Deep learned tissue "fingerprints" classify breast cancers by ER/PR/Her2 status from H&E images.
Rishi R Rawat, Itzel Ortega, +4 authors, David B Agus.
Sci Rep, 2020 May 01; 10(1). PMID: 32350370    Free PMC article.
Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer.
Carlos Perez Kerkvliet, Amy R Dwyer, +4 authors, Carol A Lange.
Breast Cancer Res, 2020 May 03; 22(1). PMID: 32357907    Free PMC article.
Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer.
Georges El Hachem, Andrea Gombos, Ahmad Awada.
F1000Res, 2019 May 10; 8. PMID: 31069063    Free PMC article.
Review.
3'-UTR Shortening Contributes to Subtype-Specific Cancer Growth by Breaking Stable ceRNA Crosstalk of Housekeeping Genes.
Zhenjiang Fan, Soyeon Kim, +2 authors, Hyun Jung Park.
Front Bioeng Biotechnol, 2020 May 16; 8. PMID: 32411683    Free PMC article.
The Healthy and Diseased Equine Endometrium: A Review of Morphological Features and Molecular Analyses.
Sandra Schöniger, Heinz-Adolf Schoon.
Animals (Basel), 2020 Apr 09; 10(4). PMID: 32260515    Free PMC article.
Review.
Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
Gil Shamai, Yoav Binenbaum, +3 authors, Ron Kimmel.
JAMA Netw Open, 2019 Jul 28; 2(7). PMID: 31348505    Free PMC article.
Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.
Zijing Zhang, Yiting Jin, +8 authors, Qiang Zou.
J Clin Lab Anal, 2019 Dec 24; 34(5). PMID: 31867779    Free PMC article.
A population-based analysis of breast cancer incidence and survival by subtype in Ontario women.
S J Seung, A N Traore, +3 authors, K J Jerzak.
Curr Oncol, 2020 Jun 04; 27(2). PMID: 32489268    Free PMC article.
Gene expression of Epithelial Membrane Protein 2 gene and β1-Integrin gene in patients with breast cancer.
Samah El-Ghlban, Elsayed Saber AbouElnour, Abd El-Monem Abd El-Kader El-Torgoman, Saeed Mohamed Saeed Abu Elabas.
Biochem Biophys Rep, 2020 Jun 04; 22. PMID: 32490210    Free PMC article.
Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Soohyeon Kwon, Soon-Hyun Ahn, +5 authors, Hyojin Kim.
J Transl Med, 2020 Jun 18; 18(1). PMID: 32546279    Free PMC article.
The age of paraffin block influences biomarker levels in archival breast cancer samples.
Hong Chen, Qing-Qing Fang, Bo Wang.
Oncol Lett, 2020 Jun 23; 20(1). PMID: 32565978    Free PMC article.
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.
I Alvarez-Lopez, S Bezares, +6 authors, A Santaballa Bertrán.
Clin Transl Oncol, 2020 Feb 14; 22(8). PMID: 32052382    Free PMC article.
Systematic Review.
Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma.
Lihua Zheng, Yaheng Zhao, +5 authors, Yunjiang Liu.
Medicine (Baltimore), 2020 Jun 27; 99(26). PMID: 32590741    Free PMC article.
Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Wei Zhang, Jing Xu, +3 authors, Jian-Jun He.
BMC Womens Health, 2020 Jul 11; 20(1). PMID: 32646416    Free PMC article.
Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
Soo-Yeon Kim, Eun-Kyung Kim, +4 authors, Min Jung Kim.
Magn Reson Imaging, 2018 Sep 03; 54. PMID: 30172938    Free PMC article.
Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.
David K Lung, Rebecca M Reese, Elaine T Alarid.
Horm Cancer, 2020 Jun 28; 11(3-4). PMID: 32592004    Free PMC article.
Review.
Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer.
Haoyu Wang, Weiwei Zhan, +3 authors, Kunwei Shen.
Breast, 2019 Nov 05; 49. PMID: 31677531    Free PMC article.
Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer.
Apurv Kulkarni, Devaki A Kelkar, +3 authors, Madhura Kulkarni.
JCO Glob Oncol, 2020 Jul 09; 6. PMID: 32639876    Free PMC article.
MicroRNA-27b-3p Promotes Tumor Progression and Metastasis by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Triple-Negative Breast Cancer.
Song-Jie Shen, Yu Song, +4 authors, Qiang Sun.
Front Oncol, 2020 Aug 28; 10. PMID: 32850439    Free PMC article.
Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
Haoyu Wang, Jiejie Yao, +3 authors, Kunwei Shen.
Cancer Med, 2020 Jul 14; 9(17). PMID: 32657039    Free PMC article.
Expression and Role of Epithelial Membrane Proteins in Tumorigenesis of Hormone Receptor-Positive Breast Cancer.
Yoon Jin Cha, Ja Seung Koo.
J Breast Cancer, 2020 Sep 11; 23(4). PMID: 32908789    Free PMC article.
Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
Fan Yang, Hong-Yan Xie, +5 authors, Zhi-Ming Shao.
Autophagy, 2020 May 14; 16(6). PMID: 32401166    Free PMC article.
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.
Sudpreeda Chainitikun, James P Long, +4 authors, Naoto T Ueno.
Breast Cancer Res Treat, 2020 Jul 29; 183(3). PMID: 32720114    Free PMC article.
High-resolution microscopy for imaging cancer pathobiology.
Yang Liu, Jianquan Xu.
Curr Pathobiol Rep, 2019 Jan 01; 7(3). PMID: 32953251    Free PMC article.
Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication.
Carolyn M Klinge.
Noncoding RNA, 2018 Dec 14; 4(4). PMID: 30545127    Free PMC article.
Review.
Microcalcification and BMP-2 in breast cancer: correlation with clinicopathological features and outcomes.
Li Zhang, Chunfang Hao, +3 authors, Zhongsheng Tong.
Onco Targets Ther, 2019 Apr 03; 12. PMID: 30936719    Free PMC article.
Introduction to Digital Image Analysis in Whole-slide Imaging: A White Paper from the Digital Pathology Association.
Famke Aeffner, Mark D Zarella, +11 authors, Douglas Bowman.
J Pathol Inform, 2019 Apr 16; 10. PMID: 30984469    Free PMC article.
Highly Cited. Review.
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Tomás Pascual, Miguel Martin, +21 authors, Aleix Prat.
Front Oncol, 2019 May 21; 9. PMID: 31106144    Free PMC article.
Association of ki67 and tumor marker p53 in locally advanced breast cancer patients and evaluation of response to neoadjuvant chemotherapy: a survey in South Iran.
Dena Firouzabadi, Alireza Rezvani, Amirreza Dehghanian, Laleh Mahmoudi.
Cancer Manag Res, 2019 Aug 03; 11. PMID: 31372050    Free PMC article.
Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions.
Fan Zhang, Yukun Cui.
Oncol Lett, 2019 Aug 20; 18(2). PMID: 31423189    Free PMC article.
Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
Harshima Disvini Wijesinghe, Gayani Kokila Wijesinghe, +4 authors, Menaka Dilani Samarawickrama Lokuhetty.
BMC Womens Health, 2020 Sep 16; 20(1). PMID: 32928183    Free PMC article.
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
Kristina A Tendl-Schulz, Fabian Rössler, +15 authors, Zsuzsanna Bago-Horvath.
Virchows Arch, 2020 May 10; 477(4). PMID: 32383007    Free PMC article.
Sociodemographic, Clinical, and Pathological Factors Influencing Outcomes in Locally Advanced Triple Negative Breast Cancer: A Brazilian Cohort.
Jesse Lopes da Silva, Bruno Henrique Rala de Paula, +2 authors, Andréia Cristina de Melo.
Breast Cancer (Auckl), 2020 Oct 09; 14. PMID: 33029072    Free PMC article.
Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy.
Mahmut Büyükşimşek, Ali Oğul, Cem Mirili, Semra Paydaş.
Eur J Breast Health, 2020 Oct 17; 16(4). PMID: 33062961    Free PMC article.
Computer-Aided Histopathological Image Analysis Techniques for Automated Nuclear Atypia Scoring of Breast Cancer: a Review.
Asha Das, Madhu S Nair, S David Peter.
J Digit Imaging, 2020 Jan 29; 33(5). PMID: 31989390    Free PMC article.
Review.
The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
Sasithorn Sujarittanakarn, Wanwisa Himakhun, Worawarn Worasawate, Wilairat Prasert.
Asian Pac J Cancer Prev, 2020 Jun 28; 21(6). PMID: 32592349    Free PMC article.
PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer.
Ramona Erber, Julia Meyer, +11 authors, Matthias Ruebner.
Cancers (Basel), 2020 Sep 30; 12(10). PMID: 32987715    Free PMC article.
Expression of MTDH and IL-10 Is an Independent Predictor of Worse Prognosis in ER-Negative or PR-Negative Breast Cancer Patients.
Pei-Yi Chu, Shin-Mae Wang, +2 authors, En-Pei Isabel Chiang.
J Clin Med, 2020 Oct 03; 9(10). PMID: 33003428    Free PMC article.
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.
Ana C Garrido-Castro, Cristina Saura, +20 authors, Jordi Rodon.
Breast Cancer Res, 2020 Nov 04; 22(1). PMID: 33138866    Free PMC article.
A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma.
Stephanie Cabarcas-Petroski, Patricio I Meneses, Laura Schramm.
BMC Cancer, 2020 Nov 13; 20(1). PMID: 33176745    Free PMC article.
Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy.
In Hee Lee, Soo Jung Lee, +5 authors, Yee Soo Chae.
BMC Cancer, 2020 Nov 18; 20(1). PMID: 33198673    Free PMC article.
A call to standardize preanalytic data elements for biospecimens.
James A Robb, Margaret L Gulley, +7 authors, Rosanna L Lapham.
Arch Pathol Lab Med, 2013 Aug 14; 138(4). PMID: 23937609    Free PMC article.
Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives.
Alina Uifălean, Stefanie Schneider, +2 authors, Cristina Adela Iuga.
Molecules, 2015 Dec 26; 21(1). PMID: 26703550    Free PMC article.
Review.
Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma.
Ji Y Park, Daegy Hong, Ji Young Park.
Pathol Oncol Res, 2017 Oct 11; 25(1). PMID: 28990139
Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers.
Miseon Lee, In Hye Song, +6 authors, Hee Jin Lee.
Cancer Res Treat, 2018 Mar 08; 51(1). PMID: 29510614    Free PMC article.
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer.
Jieun Lee, Dong-Min Kim, Ahwon Lee.
Cancer Res Treat, 2018 Aug 02; 51(2). PMID: 30064200    Free PMC article.
Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy.
Elaine M Walsh, Aliaa Shalaby, +6 authors, Grace M Callagy.
Breast Cancer Res Treat, 2018 Nov 30; 174(1). PMID: 30488345    Free PMC article.
Prognostic Value of BCL2 in Women Patients with Invasive Breast Cancer
E-Z Ayadi, B Cherif, +4 authors, R Jlidi.
Asian Pac J Cancer Prev, 2018 Dec 26; 19(12). PMID: 30583683    Free PMC article.
Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach.
Mariana Ferreira Leal, Ben P Haynes, +2 authors, Mitch Dowsett.
Breast Cancer Res Treat, 2019 Feb 24; 175(2). PMID: 30796652    Free PMC article.
What to expect from the 2018 ASCO/CAP HER2 guideline in the reflex in situ hybridization test of immunohistochemically equivocal 2+ cases?
Mónica Curado, Ana Sofia Caramelo, Catarina Eloy, António Polónia.
Virchows Arch, 2019 Apr 07; 475(3). PMID: 30953146
miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
Jieun Lee, Hee Eun Kim, +2 authors, Ahwon Lee.
Breast Cancer Res Treat, 2019 Apr 17; 176(1). PMID: 30989460    Free PMC article.
Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma.
Jing-Ping Li, Xiang-Mei Zhang, +3 authors, Yun-Jiang Liu.
Medicine (Baltimore), 2019 May 03; 98(18). PMID: 31045815    Free PMC article.
Molecular subtyping of mammary Paget's disease using immunohistochemistry.
Maria Arafah, Shoukat A Arain, +3 authors, Ahlam Al Shedoukhy.
Saudi Med J, 2019 May 06; 40(5). PMID: 31056619    Free PMC article.
PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER.
Jasmina Rajc, Irena Fröhlich, +2 authors, Josipa Flam.
Acta Clin Croat, 2019 Jun 07; 57(3). PMID: 31168174    Free PMC article.
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.
Shaveta Vinayak, Sara M Tolaney, +17 authors, Melinda L Telli.
JAMA Oncol, 2019 Jun 14; 5(8). PMID: 31194225    Free PMC article.
Highly Cited.
Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) is a Novel Predictor of Prognosis for Breast Cancer Patients: A Retrospective Case Series.
Ying Zhong, Jing Zhang, +12 authors, Qiang Sun.
Med Sci Monit, 2019 Sep 02; 25. PMID: 31473760    Free PMC article.
Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer.
Joonghyun Yoo, Bo Kyoung Seo, +6 authors, Jaehyung Cha.
Cancer Imaging, 2020 Dec 02; 20(1). PMID: 33256820    Free PMC article.
Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
Eliah R Shamir, Yunn-Yi Chen, Gregor Krings.
Mod Pathol, 2020 Jan 08; 33(6). PMID: 31907376
A Novel Model Incorporating Tumor Stiffness, Blood Flow Characteristics, and Ki-67 Expression to Predict Responses After Neoadjuvant Chemotherapy in Breast Cancer.
Jing Zhang, Song Gao, +7 authors, Yan Ma.
Front Oncol, 2020 Dec 29; 10. PMID: 33364197    Free PMC article.
Mouse Mammary Tumor Virus (MMTV)-Like env Sequence in Brazilian Breast Cancer Samples: Implications in Clinicopathological Parameters in Molecular Subtypes.
Nathália de Sousa Pereira, Glauco Akelinghton Freire Vitiello, +4 authors, Maria Angelica Ehara Watanabe.
Int J Environ Res Public Health, 2020 Dec 24; 17(24). PMID: 33352945    Free PMC article.
Anticancer Effect of Citrus hystrix DC. Leaf Extract and Its Bioactive Constituents Citronellol and, Citronellal on the Triple Negative Breast Cancer MDA-MB-231 Cell Line.
Yathsoeung Ho, Nungruthai Suphrom, +3 authors, Kanchana Usuwanthim.
Pharmaceuticals (Basel), 2020 Dec 24; 13(12). PMID: 33353129    Free PMC article.
The lingering mysteries of metastatic recurrence in breast cancer.
Alessandra I Riggio, Katherine E Varley, Alana L Welm.
Br J Cancer, 2020 Nov 27; 124(1). PMID: 33239679    Free PMC article.
Review.
The implementation of a commercially available multi-gene profile test for breast cancer characterization in a department of pathology: what have we learned from the first 100 cases?
Cristina Pelliccia, Emanuele Caselli, +3 authors, Angelo Sidoni.
Virchows Arch, 2021 Jan 07;. PMID: 33404851
Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers.
Kristen S Purrington, David Gorski, +5 authors, Manohar Ratnam.
Breast Cancer Res Treat, 2020 Apr 03; 181(1). PMID: 32236827
Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.
Rita A Mukhtar, Gregor Krings, +7 authors, Hope Rugo.
Breast Cancer Res Treat, 2020 Apr 03; 181(1). PMID: 32240457
Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy.
Astrid Botty Van den Bruele, Jessica Lavery, George Plitas, Melissa L Pilewskie.
Ann Surg Oncol, 2020 Aug 20; 28(2). PMID: 32813202    Free PMC article.
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.
Beth T Harrison, Faina Nakhlis, +4 authors, Tari A King.
Mod Pathol, 2020 Jan 15; 33(7). PMID: 31932682
Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial.
Dena Firouzabadi, Amirreza Dehghanian, +2 authors, Abdolrasoul Talei.
BMC Cancer, 2021 Jan 13; 21(1). PMID: 33430808    Free PMC article.
Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia/lymphoma.
Kyohei Yamada, Hiroaki Miyoshi, +9 authors, Koichi Ohshima.
Mod Pathol, 2020 Sep 26; 34(2). PMID: 32973330
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment.
Jesse Lopes da Silva, Fabiana Resende Rodrigues, +3 authors, Andreia Cristina de Melo.
Breast Cancer (Dove Med Press), 2021 Jan 21; 13. PMID: 33469357    Free PMC article.
Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities.
Sylvia Annabel Dass, Kim Liu Tan, +5 authors, Venugopal Balakrishnan.
Medicina (Kaunas), 2021 Jan 16; 57(1). PMID: 33445543    Free PMC article.
Review.
Automated immunohistochemical assessment ability to evaluate estrogen and progesterone receptor status compared with quantitative reverse transcription-polymerase chain reaction in breast carcinoma patients.
Taesung Jeon, Aeree Kim, Chungyeul Kim.
J Pathol Transl Med, 2020 Dec 03; 55(1). PMID: 33260290    Free PMC article.
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.
Raza Syed Hoda, Edi Brogi, +10 authors, Hannah Yong Wen.
Mod Pathol, 2020 Jul 03; 33(11). PMID: 32612248
Update on systemic treatment in early triple negative breast cancer.
Martín Núñez Abad, Silvia Calabuig-Fariñas, +6 authors, Carlos Camps Herrero.
Ther Adv Med Oncol, 2021 Feb 23; 13. PMID: 33613695    Free PMC article.
Review.
Percentage of Hormone Receptor Positivity in Breast Cancer Provides Prognostic Value: A Single-Institute Study.
Richard Sleightholm, Beth K Neilsen, +10 authors, Michael Baine.
J Clin Med Res, 2021 Feb 23; 13(1). PMID: 33613796    Free PMC article.
Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor.
Tai-Han Lin, Hong-Wei Gao, +4 authors, Cheng-Ping Yu.
Cancers (Basel), 2021 Mar 07; 13(4). PMID: 33670083    Free PMC article.
Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer.
Danian Dai, Lili Liu, +7 authors, Jihong Liu.
Front Oncol, 2021 Mar 16; 11. PMID: 33718143    Free PMC article.
Real-World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy.
Paula Cabrera-Galeana, Enrique Soto-Perez-de-Celis, +7 authors, Juan Enrique Bargallo-Rocha.
Oncologist, 2020 Apr 11; 25(12). PMID: 32275801    Free PMC article.
A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results.
Raffaella Massafra, Agnese Latorre, +13 authors, Vito Lorusso.
Front Oncol, 2021 Mar 30; 11. PMID: 33777733    Free PMC article.
q-Space Imaging Yields a Higher Effect Gradient to Assess Cellularity than Conventional Diffusion-weighted Imaging Methods at 3.0 T: A Pilot Study with Freshly Excised Whole-Breast Tumors.
Nicholas Senn, Yazan Masannat, +3 authors, Jiabao He.
Radiol Imaging Cancer, 2019 Sep 27; 1(1). PMID: 33778671    Free PMC article.
Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors.
Jian Zhang, Linhai Xiao, +3 authors, Ke Wang.
Ann Surg Oncol, 2020 Oct 24; 28(5). PMID: 33095360    Free PMC article.
XRCC5/6 polymorphisms and their interactions with smoking, alcohol consumption, and sleep satisfaction in breast cancer risk: A Chinese multi-center study.
Li-Xiang Yu, Li-Yuan Liu, +30 authors, Zhi-Gang Yu.
Cancer Med, 2021 Mar 19; 10(8). PMID: 33734613    Free PMC article.
Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort.
Rachel Martini, Yalei Chen, +30 authors, Melissa B Davis.
Sci Rep, 2021 May 01; 11(1). PMID: 33927264    Free PMC article.
Immunohistochemical Expression of Five Protein Combinations Revealed as Prognostic Markers in Asian Oral Cancer.
Hui-Ching Wang, Chien-Jung Chiang, +4 authors, Grace S Shieh.
Front Genet, 2021 May 04; 12. PMID: 33936170    Free PMC article.
Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.
Tianli Hui, Chao Shang, +3 authors, Zhenchuan Song.
Sci Rep, 2021 May 13; 11(1). PMID: 33976288    Free PMC article.
Molecular Biology in the Breast Clinics-Current status and future perspectives.
Vani Parmar, Nita S Nair, Purvi Thakkar, Garvit Chitkara.
Indian J Surg Oncol, 2021 May 18; 12(Suppl 1). PMID: 33994723    Free PMC article.
Review.
Ultrasound-Based Radiomics Analysis for Predicting Disease-Free Survival of Invasive Breast Cancer.
Lang Xiong, Haolin Chen, +6 authors, Li Li.
Front Oncol, 2021 May 18; 11. PMID: 33996546    Free PMC article.
Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing.
Luis E De Las Casas, David G Hicks.
Am J Clin Pathol, 2021 Feb 15; 155(6). PMID: 33582767    Free PMC article.
Impact of Adjuvant Treatment on Heparanase Concentration in Invasive, Unilateral Breast Cancer Patients: Results of a Prospective Single-Centre Cohort Study.
Barbara Ruszkowska-Ciastek, Kornel Bielawski, Elżbieta Zarychta, Piotr Rhone.
J Clin Med, 2021 Jun 03; 10(10). PMID: 34070058    Free PMC article.